Stem Cells & Regenerative Medicine, Princeton, NJ, USA
Event Oct 18
As stem cell research forges its way into the drug discovery and biologics pipelines of the largest pharmaceutical and biotech corporations, major issues remain: Who are the major players? What do the FDA and NIH expect? Can ethical issues be resolved? Where can smaller companies obtain funding to continue their efforts? Pioneering academic research side-by-side with commercial applications will be presented over the course of two days at the most comprehensive stem cells meeting to date!